Demystifying a Girl’s First Period

Study Background

The broad goal of these studies is to determine the physiologic and pathophysiologic underpinnings of irregular menstrual cycles among adolescents in the early postmenarchal period. Irregular menstruation affects > 2.5 million reproductive-age women in the US each year. Most adult women with oligomenorrhea of unknown etiology reporting symptoms dating back to early adolescence. While a period of cycle irregularity is well-described in the first few years after menarche, a lack of understanding of the basic mechanisms of normal reproductive axis development in the post-menarchal female has hampered our ability to distinguish abnormal from normal developmental trajectories. Moreover, the commonly held belief that menstrual irregularity among teenage girls is normal has also delayed detection of pathology in reproductive development, precluding institution of early preventative strategies to curtail future reproductive morbidity. The aim of this study is to obtain a better understanding of normal hormonal dynamics during the transition from menarche to the establishment of mature ovulatory cycles – a prerequisite for fertility. This will permit the more precise differentiation of girls with anovulatory cycles who will go on to establish regular cycles from those who may be at high-risk for long term oligomenorrhea and infertility. The interval from menarche to regular ovulatory cycles also deserves particular attention as it represents a time of unopposed estrogen exposure, an established risk factor for endometrial cancer, even among adolescents, and a potential risk factor for breast cancer.

We therefore propose the following objectives: To determine the normal reproductive axis developmental trajectory from menarche to regular ovulatory cycles (defined as at least two ovulatory cycles during the first two postmenarchal years) in a contemporary cohort of adolescent girls. We hypothesize that the temporal sequence of reproductive maturation will consist of anovulatory cycles (representing a time of unopposed estrogen exposure), ovulatory cycles with a short luteal phase (estrogen with low progesterone exposure), and finally, ovulatory cycles with a normal luteal phase length (estrogen action fully counterbalanced by progesterone action).

Eligibility Criteria

• Girls 8–14 years old
• Have some breast development
• Have had no more than four periods
• Healthy weight, defined as having body weight >85% of expected (EBW) and a body mass index (BMI) <99th%

Principal Investigator

Natalie D. Shaw, M.D., MMSc.
Principal Investigator

Tel 984-287-3716
natalie.shaw@nih.gov

Curriculum Vitae Natalie D. Shaw (152KB)
NIH Intramural Profile

P.O. Box 12233

Mail Drop D3-02

Durham, N.C. 27709

Delivery Instructions